Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$41.71 - $52.9 $335,932 - $426,056
8,054 New
8,054 $370,000
Q1 2023

May 12, 2023

BUY
$23.85 - $31.34 $232,632 - $305,690
9,754 New
9,754 $285,000
Q1 2021

May 10, 2021

SELL
$30.93 - $59.48 $520,087 - $1 Million
-16,815 Closed
0 $0
Q4 2020

Feb 03, 2021

BUY
$18.53 - $31.5 $311,581 - $529,672
16,815 New
16,815 $519,000
Q2 2020

Aug 11, 2020

SELL
$8.5 - $15.82 $228,769 - $425,779
-26,914 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$7.25 - $19.22 $195,126 - $517,287
26,914 New
26,914 $247,000
Q4 2019

Feb 12, 2020

SELL
$13.77 - $19.2 $260,487 - $363,206
-18,917 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$14.93 - $19.83 $282,430 - $375,124
18,917 New
18,917 $286,000
Q2 2019

Aug 06, 2019

SELL
$15.01 - $18.89 $479,479 - $603,422
-31,944 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$16.23 - $20.29 $122,633 - $153,311
-7,556 Reduced 19.13%
31,944 $559,000
Q4 2018

Feb 12, 2019

BUY
$10.77 - $18.44 $425,415 - $728,380
39,500 New
39,500 $687,000
Q3 2018

Nov 13, 2018

SELL
$9.1 - $14.8 $332,150 - $540,200
-36,500 Closed
0 $0
Q2 2018

Aug 09, 2018

SELL
$9.6 - $14.6 $423,360 - $643,860
-44,100 Reduced 54.71%
36,500 $354,000
Q1 2018

May 11, 2018

BUY
$5.7 - $12.3 $459,420 - $991,380
80,600 New
80,600 $802,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.76B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.